- Home
- VCEL vs NYMTM Comparison
VCEL vs NYMTM Comparison
Compare VCEL & NYMTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- NYMTM
- Stock Information
- Founded
- VCEL 1989
- NYMTM N/A
- Country
- VCEL United States
- NYMTM United States
- Employees
- VCEL N/A
- NYMTM 70
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- NYMTM Real Estate Investment Trusts
- Sector
- VCEL Health Care
- NYMTM Real Estate
- Exchange
- VCEL Nasdaq
- NYMTM Nasdaq
- Market Cap
- VCEL 2.1B
- NYMTM N/A
- IPO Year
- VCEL 1997
- NYMTM N/A
- Fundamental
- Price
- VCEL $39.98
- NYMTM $24.64
- Analyst Decision
- VCEL Strong Buy
- NYMTM
- Analyst Count
- VCEL 8
- NYMTM 0
- Target Price
- VCEL $62.00
- NYMTM N/A
- AVG Volume (30 Days)
- VCEL 463.0K
- NYMTM N/A
- Earning Date
- VCEL 07-31-2025
- NYMTM N/A
- Dividend Yield
- VCEL N/A
- NYMTM N/A
- EPS Growth
- VCEL 521.85
- NYMTM N/A
- EPS
- VCEL 0.05
- NYMTM N/A
- Revenue
- VCEL $238,541,000.00
- NYMTM N/A
- Revenue This Year
- VCEL $23.03
- NYMTM N/A
- Revenue Next Year
- VCEL $24.52
- NYMTM N/A
- P/E Ratio
- VCEL $771.35
- NYMTM N/A
- Revenue Growth
- VCEL 14.80
- NYMTM N/A
- 52 Week Low
- VCEL $37.39
- NYMTM N/A
- 52 Week High
- VCEL $63.00
- NYMTM N/A
- Technical
- Relative Strength Index (RSI)
- VCEL 42.08
- NYMTM 51.81
- Support Level
- VCEL $39.39
- NYMTM $24.50
- Resistance Level
- VCEL $42.61
- NYMTM $24.76
- Average True Range (ATR)
- VCEL 1.61
- NYMTM 0.15
- MACD
- VCEL -0.20
- NYMTM 0.00
- Stochastic Oscillator
- VCEL 11.60
- NYMTM 71.83
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About NYMTM New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets. Geographically operates in USA states California, New York, Florida, New Jersey, Illinois, maximum from California.